HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inari Medical, Inc. (NARI) Investors with Substantial Losses to Contact Firm, NARI Plummets on News of DOJ Investigation – Hagens Berman
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now .
- SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now .
- Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.
- This news sent the price of Inari shares crashing $12.14, or down about 21%, on Feb. 29, 2024.
- Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.